Ignite Creation Date:
2025-12-24 @ 2:34 PM
Ignite Modification Date:
2026-02-18 @ 2:07 PM
Study NCT ID:
NCT04229459
Status:
RECRUITING
Last Update Posted:
2020-01-18
First Post:
2020-01-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trial of Nivolumab and Cetuximab After Chemoradiation in Esophageal Squamous Cell Carcinoma Patients.
Sponsor:
Baruch Brenner
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-12-30
Start Date Type:
ACTUAL
Primary Completion Date:
2022-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-06
Completion Date Type:
ESTIMATED
First Submit Date:
2020-01-13
First Submit QC Date:
None
Study First Post Date:
2020-01-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-01-13
Last Update Post Date:
2020-01-18
Last Update Post Date Type:
ACTUAL